4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-034062
Director sold 6,441 shares at $9.90 ($63,779)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watkins Thomas Director | 2022-06-02 | Option exercise | +15,000 | $4.15 | $62,250 | 69,505 | D |
| Watkins Thomas Director | 2022-06-02 | Sale | −6,441 | $9.90 | $63,779 | 63,064 | D |
| Derivatives | |||||||
| Watkins Thomas Director | 2022-06-02 | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | D | ||
| Open-market sales · 6,441 sh · avg $9.90 · $63,779 | |||||||
Loading xslF345X03/doc4.xml…